LAMP2

protein-coding

lysosomal associated membrane protein 2, the group of CD molecules|Lysosome associated membrane proteins

Gene summary

The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]

MANE transcript

NM_002294.3

Inheritance

XL

ClinVar variants

P:145U:304B:177

Top phenotype

Danon disease

gnomAD constraint

pLI —, LoF o/e 0.25

Max pathogenic AF

—

Genomic locus

chrX:120,426,148-120,469,365

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~43.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Danon diseaseSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010281

Submitter: PanelApp Australia

Danon diseaseSUPPORTIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010281

Submitter: Orphanet

Danon diseaseDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010281

Submitter: G2P

Danon diseaseDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010281

Submitter: ClinGen

The LAMP2 gene is associated with Danon disease, an X-linked disorder characterized by vacuolar cardiomyopathy, and to a lesser extent skeletal myopathy, cognitive defects and retinopathy (reviewed in Rowland et al., 2016 PMID: 27165304). As an X-linked disorder males are predominantly affected but heterozygous female carriers have been shown to develop cardiomyopathy, albeit with abated progression compared to affected males (Boucek et al., 2011 PMID: 21415759). The majority of mutations are LOF (frameshift and non-sense) but missense, splice site, and large copy number variants (CNVs), both duplications and deletions, have been reported, as well as de novo mutations. LAMP2 has three different splice isoforms (LAMP-2A, LAMP-2B, LAMP-2C) due to alternative splicing in exon 9 (terminal exon). The LAMP-2B isoform is the most widely implicated in Danon Disease, as it is found to be most abundantly expressed in the heart, skeletal muscle and brain (Konecki et al., 1995 PMID: 7488019), but does not negate the other isoforms as having a role in disease. LAMP2 is the lysosomal-associated membrane protein 2 and functions as a receptor to mediate lysosomal associated degradation or proteins, or autophagy (reviewed in D’Souza et al., 2014, PMID: 25228319). Multiple cases are reported in the literature but the maximum score for genetic evidence (12 pts) has been reached. The mechanism for disease is disrupted autophagy that results in aberrant vacuole accumulation in cells. This gene-disease association is supported by the function of the gene product, alteration in normal function in non-patient cells, and animal models. In summary, LAMP2 is definitively associated with Danon disease. This association has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Data on the occurrence of cardiomyopathy in individuals with Danon disease was collected by the Hypertrophic Cardiomyopathy Gene Curation Committee (subgroup of the Cardiovascular Working Group). Mutation of LAMP2 results in the development of hypertrophic cardiomyopathy (in 88% of cases of Danon disease) that rapidly progresses to dilated cardiomyopathy (reviewed in Rowland et al., 2016 PMID: 27165304). The progression of cardiomyopathy is caused by aberrant accumulation of autophagic vacuoles in the heart and skeletal muscle. The progressive nature of LAMP2-associated cardiomyopathy requires heart transplantation by the third decade in order to avoid death (reviewed in D’Souza et al., 2014, PMID: 25228319).

Danon diseaseSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010281

Submitter: Labcorp Genetics (formerly Invitae)

Danon diseaseSTRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010281

Submitter: Genomics England PanelApp

Clinical Genomic Database (CGD)

Danon diseaseXL

Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic

Intervention: Cardiovascular

Rationale: Surveillance (eg, with EKG and electrocardiogram) and medical management can help decrease morbidity related to cardiomyopathy and arrhythmias; Heart transplant has been suggested to be the only truly effective treatment

Comments: Males typically display mental retardation and other recognizable features, but females may be affected with cardiomyopathy and arrhthymias

Refs: 6450334; 3806120; 3057987; 8504498; 7919972; 10972294; 12084876; 15253947; 15673802; 15889279; 15792868; 15907287; 17899313; 19318653; 21161685; 21816855; 22074992; 22365987; 22541782; 22750798Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to LAMP2 variants in ClinVar

13 Conditions Cataloged
Danon diseaseTotal: 558
Cardiovascular phenotypeTotal: 175
not providedTotal: 158
not specifiedTotal: 109
LAMP2-related disorderTotal: 30
CardiomyopathyTotal: 24
LAMP2-related disordersTotal: 14
Hypertrophic cardiomyopathyTotal: 13

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002294.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
22
clinvar
113
clinvar
1
clinvar
137
missense
3
clinvar
250
clinvar
58
clinvar
4
clinvar
315
nonsense
33
clinvar
7
clinvar
9
clinvar
1
clinvar
50
start loss
2
clinvar
4
clinvar
6
frameshift
55
clinvar
19
clinvar
1
clinvar
75
splice donor/acceptor (+/-2bp)
9
clinvar
12
clinvar
22
clinvar
43
Total102433041716626

Highest pathogenic variant AF is 9.1760796e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 53 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002294.3RefSeqNP_002285.19MANE Select
ENST00000200639.9EnsemblENSP00000200639.49MANE Select
NM_001122606.1RefSeqNP_001116078.19Standard
NM_013995.2RefSeqNP_054701.19Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Phagosome - Homo sapiens (human)
  • Autophagy - animal - Homo sapiens (human)
  • Lysosome - Homo sapiens (human)
  • Tuberculosis - Homo sapiens (human)
  • Senescence and Autophagy in Cancer

Biological Process

  • platelet degranulation
  • protein targeting
  • cellular response to starvation
  • protein import
  • regulation of protein stability

Molecular Function

  • protein binding
  • enzyme binding
  • protein domain specific binding

Cellular Component

  • extracellular space
  • lysosome
  • lysosomal membrane
  • late endosome
  • plasma membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000434600
Coding exons
9
Length
41539
Individuals with no LoFs
125723
Homozygous LoFs
1
Heterozygous LoFs
4
Defined
125728
p
0.0000199
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.8401161440.8030.000009982690
Missense (PolyPhen)2135.7440.5875717
Synonymous1.064352.80.8150.00000356818
Loss of Function2.42312.10.2488.34e-7231

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.000180.00011rare
Finnish00.0absent
European (Non-Finnish)0.0000240.000018rare
South Asian0.0000520.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Plays an important role in chaperone-mediated autophagy, a process that mediates lysosomal degradation of proteins in response to various stresses and as part of the normal turnover of proteins with a long biological half-live (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125, PubMed:27628032). Functions by binding target proteins, such as GAPDH and MLLT11, and targeting them for lysosomal degradation (PubMed:8662539, PubMed:11082038, PubMed:18644871, PubMed:24880125). Plays a role in lysosomal protein degradation in response to starvation (By similarity). Required for the fusion of autophagosomes with lysosomes during autophagy (PubMed:27628032). Cells that lack LAMP2 express normal levels of VAMP8, but fail to accumulate STX17 on autophagosomes, which is the most likely explanation for the lack of fusion between autophagosomes and lysosomes (PubMed:27628032). Required for normal degradation of the contents of autophagosomes (PubMed:27628032). Required for efficient MHCII-mediated presentation of exogenous antigens via its function in lysosomal protein degradation; antigenic peptides generated by proteases in the endosomal/lysosomal compartment are captured by nascent MHCII subunits (PubMed:20518820). Is not required for efficient MHCII-mediated presentation of endogenous antigens (PubMed:20518820). {ECO:0000250|UniProtKB:P17046, ECO:0000269|PubMed:11082038, ECO:0000269|PubMed:18644871, ECO:0000269|PubMed:20518820, ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:27628032, ECO:0000269|PubMed:8662539}.;
Disease
DISEASE: Danon disease (DAND) [MIM:300257]: DAND is a lysosomal glycogen storage disease characterized by the clinical triad of cardiomyopathy, vacuolar myopathy and mental retardation. It is often associated with an accumulation of glycogen in muscle and lysosomes. {ECO:0000269|PubMed:15673802, ECO:0000269|PubMed:15907287}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.618

Intolerance Scores

RVIS EVS
0.11
RVIS percentile EVS
61.73

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.150

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.